Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)

NCT05369052 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

865

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Foot Infection

Interventions

DRUG: contezolid acefosamil (IV)/contezolid (PO)
DRUG: Linezolid (IV and PO)

Sponsor

MicuRx